Choosing the Number of Doses and the Cohort Size for Phase 1 Dose-Escalation Studies
暂无分享,去创建一个
[1] J O'Quigley,et al. Dose‐Finding Designs for HIV Studies , 2001, Biometrics.
[2] John Whitehead,et al. Bayesian decision procedures for dose-escalation based on evidence of undesirable events and therapeutic benefit. , 2006, Statistics in medicine.
[3] J Whitehead,et al. Bayesian decision procedures based on logistic regression models for dose-finding studies. , 1998, Journal of biopharmaceutical statistics.
[4] L V Rubinstein,et al. A comparison of two phase I trial designs. , 1994, Statistics in medicine.
[5] J Whitehead,et al. Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers. , 2001, Biostatistics.
[6] J Whitehead,et al. Bayesian decision procedures for dose determining experiments. , 1995, Statistics in medicine.
[7] D. Kerr,et al. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] S. Møller,et al. An extension of the continual reassessment methods using a preliminary up-and-down design in a dose finding study in cancer patients, in order to investigate a greater range of doses. , 1995, Statistics in medicine.
[9] S Zohar,et al. The continual reassessment method: comparison of Bayesian stopping rules for dose‐ranging studies , 2001, Statistics in medicine.
[10] J Whitehead,et al. A novel Bayesian decision procedure for early-phase dose-finding studies. , 1999, Journal of biopharmaceutical statistics.
[11] Ethan Reiner,et al. A stopping rule for the continual reassessment method , 1998 .
[12] Yinghui Zhou,et al. Practical Implementation of Bayesian Dose-Escalation Procedures , 2003 .
[13] J O'Quigley,et al. Continual reassessment method: a practical design for phase 1 clinical trials in cancer. , 1990, Biometrics.
[14] I. Todd,et al. The Design of Clinical Trials in Cancer Therapy , 1972, British Journal of Cancer.
[15] Thomas M Braun,et al. The bivariate continual reassessment method. extending the CRM to phase I trials of two competing outcomes. , 2002, Controlled clinical trials.